Larimar Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases, with a primary focus on Friedreich ataxia. The company uses its proprietary platform to develop protein replacement therapies delivered via intrathecal administration. Larimar is advancing its lead candidate through clinical trials targeting mitochondrial diseases and genetic disorders.